MedPath

NU-DERM System NORMAL-Oily

OBAGI NU-DERM SYSTEM

Approved
Approval ID

4a96c769-4914-4eb8-8530-e4afb80c8c94

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 19, 2023

Manufacturers
FDA

OBAGI COSMECEUTICAL LLC

DUNS: 790553353

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

HYDROQUINONE, HOMOSALATE, OCTISALATE, and ZINC OXIDE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code62032-531
Product Classification
G
Generic Name
HYDROQUINONE, HOMOSALATE, OCTISALATE, and ZINC OXIDE
Product Specifications
Effective DateJanuary 19, 2023
FDA Product Classification

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

NU-DERM System NORMAL-Oily - FDA Drug Approval Details